Tender detail
Supply of enfortumab vedotin 30 mg for B.141 treatment of patients with urothelial cancer
Summary
The University Clinical Hospital in Poznań is procuring enfortumab vedotin in a 30 mg dose for the B.141 programme treating patients with urothelial cancer. The notice does not specify the quantity or divide the procurement into lots.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.